Efficacy of Neoadjuvant Chemotherapy DOX and XELOX Regimens for Patients with Resectable Gastric or Gastroesophageal Junction Adenocarcinoma

Table 2

Serious adverse events with perioperative morbidity.

	DOX ()	XELOX ()	Surgery ()		value
Patients with at least one serious adverse event involving a perioperative morbidity	31	22	20	4.008	0.135
Surgical complication
Pneumonia	8	7	7	0.11	0.946
Pleural complication	15	5	11	5.41	0.067
Chyle leakage	1	0	0	2.018	0.365
Seroperitoneum	1	1	1	0.001	1.000
Anastomotic fistula	1	1	0	1.035	0.596
Intestinal occlusion	0	0	1	1.954	0.376